RÉSUMÉ
Objective To explore the potential categories and influencing factors of the fear of progression in patients with inflammatory bowel diseases(IBD).Methods IBD patients who received inpatient treatment in a tertiary hospital in Nanjing from July 2022 to July 2023 were selected as the study subjects by convenience sampling method.The General Demographic Information Questionnaire,the Chinese version of the Fear of Progression Questionnaire-Short Form(FoP-Q-SF),the Chinese version of Inflammatory Bowel Disease Self-efficacy Scale(IBD-SES),and Social Support Rating Scale(SSRS)were administered to the participants.We applied one-way ANOVA and Logistic regression analysis to identify the factors associated with the potential categories of the fear of progression.Results A total of 303 retumed questionnaires(out of the 310)were valid,resulting an effective response rate of 97.74％.According to the results of latent profile analysis,we classified the respondents into 3 categories by the fear of progression,namely"low risk fear of disease adaptation group"(n=127,41.91％),"medium risk fear of illness distress group"(n=139,45.88％),"high risk fear of dysfunction group"(n=37,12.21％).3 groups showed statistically significant differences in permanent address,self-rated financial pressure,current disease status and self-efficacy(P＜0.05).Conclusion Patients with IBD had obvious differences in characteristics on the fear of progression.Nursing personnel should formulate personalized intervention strategies based on the classification characteristics of the fear of progression of IBD patients.Moreover,nurses should focus on improving patients'self-efficacy and promoting patients to treat medical care,stress and emotion management correctly.
RÉSUMÉ
Objective:To explore the mediating roles of family resilience and perceived social support between fear of progression and quality of life in patients with adult pulmonary hypertension, so as to provide guidance for grassroots medical staff to deeply understand and improve the long-term quality of life of adult pulmonary hypertension patients.Methods:Using a convenience sampling method, 219 adult pulmonary hypertension patients who attended Qilu Hospital, Shandong University from July 2021 to February 2022 were selected for a cross-sectional study using the World Health Organization Quality of Life Questionnaire Abbreviated Version (WHOQOL-BREF), Perceived Social Support Scale (PSSS), Shortened Chinese version of the Family Resilience Assessment Scale (FRAS-C) and Chinese version of Fear of Progression Questionnaire-Short Form (FoP-Q-SF) for investigation. A structural equation model was established to evaluate the mediating effect of family resilience and perceived social support on fear of progression and quality of life.Results:The scores of WHOQOL-BREF, PSSS, FRAS-C, and FoP-Q-SF were (45.85 ± 10.22), 66(56, 75), 94(89, 97) and 39(32, 46) points in adult pulmonary hypertension patients. The total scores of WHOQOL-BREF were negatively correlated with FoP-Q-SF ( r = -0.63, P<0.01), and positively correlated with FRAS-C and PSSS ( r=0.54, 0.46, both P<0.01). Family resilience played a partial mediating role between fear of progression and quality of life, accounting for 13.43% of the total effect. Family resilience and perceived social support played a chain mediating role between fear of progression and quality of life, accounting for 2.71% of the total effect. Conclusions:Family resilience-perceived social support play mediating roles between fear of progression and quality of life, healthcare workers can alleviate fear of progression and improve quality of life by promoting the levels of family resilience and perceived social support of adult pulmonary hypertension parents.
RÉSUMÉ
Objective:To explore the impact of supportive-expressive group therapy on the fear of disease progression and self-perceived burden of patients with early chronic kidney disease (CKD).Methods:A total of 150 early CKD patients in the Nephrology Department of Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine from May 2018 to July 2020 were selected and divided into research group with 88 cases and control group with 88 cases by random number table method. There were 12 cases were lost in the research group, 14 cases were lost in the control group. 76 cases in the research group and 74 cases in the control group were involved in the statistical analysis. The control group was treated with routine nursing while the research group was treated with nursing measures based on supportive-expressive group therapy as well as routine nursing. The effect of intervention was assessed by Fear of disease Progression (FoP) Questionnaire and Self-Perceived Burden Scale (SPBS) before and 12 weeks after the intervention.Results:There was no significant difference in the scores of FoP and Self Perceived Burden Scale (SPBS) between the two groups before the intervention ( P>0.05). After intervention, the scores of emotional reactions, loss of autonomy, partnership/family, anxiety response and the total score of FoP in the research group were (35.79 ± 5.82), (18.52 ± 3.16), (16.23 ± 2.27), (21.57 ± 2.92), (110.81 ± 17.12) respectively, which were lower than those in the control group (47.61 ± 7.13), (24.61 ± 3.97), (24.52 ± 3.71), (31.67 ± 3.87), (147.32 ± 21.72), and the differences were statistically significant ( t values were -18.07 - -10.41, all P<0.05). After intervention, the scores of physical factors, emotional factors and the total score of SPBS in the research group were (10.15 ± 1.82), (10.17 ± 1.86), (24.01 ± 4.25), which were lower than those in the control group (15.87 ± 2.57), (16.81 ± 3.14), (36.39 ± 6.32), and the differences were statistically significant ( t values were -15.76, -15.92, -14.11, all P<0.05). Conclusions:Supportive-expressive group therapy can effectively reduce the early CKD patients′ fear of disease progression and relieve their self-perceived burden.
RÉSUMÉ
Objective:To explore the effect of supportive-expressive therapy (SET) on fear of progression and resilience in lymphoma patients, to provide reference for clinical nursing care.Methods:A total of 86 patients with lymphoma treated in the First Affiliated Hospital of Nanjing Medical University from February 2019 to September 2020 were divided into experimental group and control group according to random number table method, with 43 cases in each group. The control group was given conventional nursing, while the experimental group was applied with 6 times SET. Before and after intervention, the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) and Connor Davidson Resilience Scale (CD-RISC) was evaluated between two groups.Results:Finally, 40 cases were included in the experimental group and 42 cases in the control group. There was no significant difference between each dimension and total score of the two groups before intervention ( P>0.05). After intervention, scores of physiological health dimension, social and family dimension, and total FoP-Q-SF were (14.90 ± 3.96) points, (15.03 ± 4.29) points and (29.93 ± 5.65) points in the experimental group, significantly lower than those in the control group (17.71 ± 3.38) points, (17.29 ± 4.03) points and (35.00 ± 5.57) points ( t=3.47, 2.46, 4.10, all P<0.05); scores of tenacity, strength, optimism dimension and total CD-RISC were (28.08 ± 4.47) points, (21.30 ± 5.58) points, (10.65 ± 2.97) points and (60.03 ± 8.42) points in the experimental group, significantly higher than those in the control group (24.31 ± 4.11) points, (17.98 ± 4.13) points, (9.26 ± 2.47) points and (51.55 ± 5.86) points, the differences were statistically significant ( t values were 2.30-5.27, all P<0.05). Conclusions:SET can effectively alleviate the degree of fear of progression and promote resilience of lymphoma patients.
RÉSUMÉ
@#Introduction: Fear of cancer progression may lead to worsening of psychological complications of cancer and affects the quality of life of cancer patients. Hence, fear of cancer progression needs to be monitored. This study translated the original English version of the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) into the Malay language and investigated the reliability and validity of the Malay version of the FoP-Q-SF (FoP-Q-SF-M) among Malaysian cancer patients. Methods: Concurrent translation and back translation of the English version of the FoP-Q-SF to the FoP-Q-SF-M was performed, and the FoP-Q-SF-M and the Malay version of the Cancer Therapy Satisfaction Questionnaire (CTSQ-M) (as a comparison to assess the discriminant validity of the FoP-Q-SF-M) were administered to 200 cancer patients with different sites, stages, and duration of cancer diagnosis. Results: The CTSQ-M exhibited excellent internal consistency (Cronbach’s α= 0.927) as well as demonstrated good convergent and discriminant validity. Exploratory factor analysis of the FoP-Q-SF-M extracted one factor with twelfth items, thereby this supports the single-factor model reported by the English version of the FoP-Q-SF. Conclusion: The FoP-Q-SF-M exhibited acceptable psychometric properties and valid for use to assess fear of cancer progression in the Malaysian cancer population.
RÉSUMÉ
Background: Inflammatory bowel disease (IBD) is a recurrent disease with unknown etiology. Psychological disorders such as anxiety, depression and fear are commonly seen in IBD patients and seriously reduce the quality of life. Aims: To investigate the current status of fear of progression in patients with IBD and its relationship with the quality of life. Methods: IBD patients admitted to the Department of Gastroenterology, Xijing Hospital, Air Force Medical University from October 2020 to December 2020 were enrolled consecutively. The demographic data and clinical data on disease course and severity were collected. A questionnaire survey was conducted by using Fear of Progression Questionnaire-Short Form (FoP-Q-SF) and the MOS 36-Item Short-Form Health Survey (SF-36). Results: A total of 225 IBD patients were enrolled, including 146 cases of ulcerative colitis (UC) and 79 cases of Crohn's disease (CD). The mean score of FoP-Q-SF was 34.89±9.70. Using 34 points as the cut-off value, 53.3% of the IBD patients were identified as fear of progression. The FoP-Q-SF score in CD patients was significantly higher than that in UC patients (36.92±10.47 vs. 33.80±9.11, P<0.05). Fear of progression was positively correlated with the disease activity and severity in both UC and CD patients (all P<0.05), whereas age was negatively correlated with fear of progression (P<0.05). In patients with FoP-Q-SF score equal or greater than 34 points, scores of 5 health concepts of SF-36 scale, including physical functioning, role-physical, role-emotional, mental health, and general health were significantly lower than those with FoP-Q-SF score less than 34 points (all P<0.05). In addition, the quality of life was also affected by age, education level and length of disease course. Conclusions: Fear of progression is prevalent in IBD patients and may affect the quality of life, and is correlated with disease type (UC/CD), age and activity and severity of the disease.